Change from baseline in FACIT-Fatigue scores (mean ± SE) during eculizumab treatment. Patients received eculizumab for up to 52 weeks. P value is based on change from baseline using a signed rank test. (FACIT indicates Functional Assessment of Chronic Illness Therapy.)